{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T11:24:56Z","timestamp":1794655496853,"version":"4.9.1"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T00:00:00Z","timestamp":1698969600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"DH Chen Foundation","award":["R-86U55A"],"award-info":[{"award-number":["R-86U55A"]}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01-LM012595"],"award-info":[{"award-number":["R01-LM012595"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Brain"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Non-familial Alzheimer\u2019s disease (AD) occurring before 65\u00a0years of age is commonly referred to as early-onset Alzheimer\u2019s disease (EOAD) and constitutes\u2009~\u20095\u20136% of all AD cases\u00a0(Mendez et al. in Continuum 25:34\u201351, 2019). While EOAD exhibits the same clinicopathological changes such as amyloid plaques, neurofibrillary tangles (NFTs), brain atrophy, and cognitive decline (Sirkis et al. in Mol Psychiatry 27:2674\u201388, 2022; Caldwell et al. in Mol Brain 15:83, 2022) as observed in the more prevalent late-onset AD (LOAD), EOAD patients tend to have more severe cognitive deficits, including visuospatial, language, and executive dysfunction (Sirkis et al. in Mol Psychiatry 27:2674\u201388, 2022). Patient-derived induced pluripotent stem cells (iPSCs) have been used to model and study penetrative, familial AD (FAD) mutations in <jats:italic>APP<\/jats:italic>, <jats:italic>PSEN1<\/jats:italic>, and <jats:italic>PSEN2<\/jats:italic> (Valdes et al. in Research Square 1\u201330, 2022; Caldwell et al. in Sci Adv 6:1\u201316, 2020) but have been seldom used for sporadic forms of AD that display more heterogeneous disease mechanisms. In this study, we sought to characterize iPSC-derived neurons from EOAD patients via RNA sequencing. A modest difference in expression profiles between EOAD patients and non-demented control (NDC) subjects resulted in a limited number of differentially expressed genes (DEGs). Based on this analysis, we provide evidence that iPSC-derived neuron model systems, likely due to the loss of EOAD-associated epigenetic signatures arising from iPSC reprogramming, may not be ideal models for studying sporadic AD.<\/jats:p>","DOI":"10.1186\/s13041-023-01063-5","type":"journal-article","created":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T10:02:35Z","timestamp":1699005755000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Limitations of the human iPSC-derived neuron model for early-onset Alzheimer\u2019s disease"],"prefix":"10.1186","volume":"16","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3165-7235","authenticated-orcid":false,"given":"Phoebe","family":"Valdes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3440-107X","authenticated-orcid":false,"given":"Kenneth W.","family":"Henry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3693-0854","authenticated-orcid":false,"given":"Michael Q.","family":"Fitzgerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5651-5335","authenticated-orcid":false,"given":"Koushik","family":"Muralidharan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2850-7677","authenticated-orcid":false,"given":"Andrew B.","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4912-0279","authenticated-orcid":false,"given":"Srinivasan","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0636-9186","authenticated-orcid":false,"given":"Lawrence S. B.","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6408-9548","authenticated-orcid":false,"given":"William C.","family":"Mobley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6195-3241","authenticated-orcid":false,"given":"Douglas R.","family":"Galasko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8059-4659","authenticated-orcid":false,"given":"Shankar","family":"Subramaniam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,3]]},"reference":[{"key":"1063_CR1","doi-asserted-by":"crossref","unstructured":"Mendez MF. Early-onset Alzheimer Disease and Its Variants. Continuum (Minneap Minn). 2019;25:34\u201351.","DOI":"10.1212\/CON.0000000000000687"},{"key":"1063_CR2","doi-asserted-by":"publisher","first-page":"2674","DOI":"10.1038\/s41380-022-01531-9","volume":"27","author":"DW Sirkis","year":"2022","unstructured":"Sirkis DW, Bonham LW, Johnson TP, La Joie R, Yokoyama JS. Dissecting the clinical heterogeneity of early-onset Alzheimer\u2019s disease. Mol Psychiatry. 2022;27:2674\u201388.","journal-title":"Mol Psychiatry"},{"key":"1063_CR3","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s13041-022-00963-2","volume":"15","author":"AB Caldwell","year":"2022","unstructured":"Caldwell AB, Anantharaman BG, Ramachandran S, Nguyen P, Liu Q, Trinh I, et al. Transcriptomic profiling of sporadic Alzheimer\u2019s disease patients. Mol Brain. 2022;15:83.","journal-title":"Mol Brain"},{"key":"1063_CR4","doi-asserted-by":"publisher","unstructured":"Valdes P, Caldwell A, Liu Q, Fitzgerald M, Ramachandran S, Karch C, et al. Integrative multiomics reveals common endotypes across PSEN1, PSEN2, and APP mutations in familial Alzheimer\u2019s disease. Research Square. 2022;1-30. https:\/\/doi.org\/10.21203\/rs.3.rs-2356131\/v1","DOI":"10.21203\/rs.3.rs-2356131\/v1"},{"key":"1063_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1126\/sciadv.aba5933","volume":"6","author":"AB Caldwell","year":"2020","unstructured":"Caldwell AB, Liu Q, Schroth GP, Galasko DR, Yuan SH, Wagner SL, et al. Dedifferentiation and neuronal repression define familial Alzheimer\u2019s disease. Sci Adv. 2020;6:1\u201316.","journal-title":"Sci Adv"},{"key":"1063_CR6","doi-asserted-by":"publisher","first-page":"1836","DOI":"10.1038\/nprot.2012.116","volume":"7","author":"Y Shi","year":"2012","unstructured":"Shi Y, Kirwan P, Livesey FJ. Directed differentiation of human pluripotent stem cells to cerebral cortex neurons and neural networks. Nat Protoc. 2012;7:1836\u201346.","journal-title":"Nat Protoc"},{"key":"1063_CR7","doi-asserted-by":"crossref","unstructured":"Henneges C, Reed C, Chen Y-F, Dell\u2019Agnello G, Lebrec J. Describing the sequence of cognitive decline in alzheimer\u2019s disease patients: results from an observational study. J Alzheimers Dis. 2016;52:1065\u201380.","DOI":"10.3233\/JAD-150852"},{"key":"1063_CR8","volume":"2015","author":"DH Davis","year":"2015","unstructured":"Davis DH, Creavin ST, Yip JL, Noel-Storr AH, Brayne C, Cullum S. Montreal cognitive assessment for the diagnosis of Alzheimer\u2019s disease and other dementias. Cochrane Database Syst Rev. 2015;2015: CD010775.","journal-title":"Cochrane Database Syst Rev"},{"key":"1063_CR9","unstructured":"Neuronal, neural stem cell and glial cell markers | Abcam. https:\/\/www.abcam.com\/neuroscience\/neural-markers-guide. Accessed 29 Aug 2023."},{"key":"1063_CR10","unstructured":"CNS Cell Markers | GeneTex. Available from: https:\/\/www.genetex.com\/Research\/Overview\/neuroscience\/CNS_cell_markers. Accessed 11 Apr 2023."},{"key":"1063_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.neurobiolaging.2018.12.016","volume":"76","author":"A Gatt","year":"2019","unstructured":"Gatt A, Lee H, Williams G, Thuret S, Ballard C. Expression of neurogenic markers in Alzheimer\u2019s disease: a systematic review and metatranscriptional analysis. Neurobiol Aging. 2019;76:166\u201380.","journal-title":"Neurobiol Aging"},{"key":"1063_CR12","doi-asserted-by":"publisher","first-page":"108","DOI":"10.1186\/s13041-019-0522-8","volume":"12","author":"H Hagihara","year":"2019","unstructured":"Hagihara H, Murano T, Ohira K, Miwa M, Nakamura K, Miyakawa T. Expression of progenitor cell\/immature neuron markers does not present definitive evidence for adult neurogenesis. Mol Brain. 2019;12:108.","journal-title":"Mol Brain"},{"key":"1063_CR13","unstructured":"Neuronal and Glial Cell Markers. Cell signaling technology. https:\/\/www.cellsignal.com\/pathways\/neuronal-and-glial-cell-markers. Accessed 11 Apr 2023."},{"key":"1063_CR14","doi-asserted-by":"publisher","first-page":"1533","DOI":"10.1016\/j.stem.2021.04.004","volume":"28","author":"J Mertens","year":"2021","unstructured":"Mertens J, Herdy JR, Traxler L, Schafer ST, Schlachetzki JCM, B\u00f6hnke L, et al. Age-dependent instability of mature neuronal fate in induced neurons from Alzheimer\u2019s patients. Cell Stem Cell. 2021;28:1533-1548.e6.","journal-title":"Cell Stem Cell"},{"key":"1063_CR15","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.960906","author":"Z Qiu","year":"2022","unstructured":"Qiu Z, Bai X, Ji X, Wang X, Han X, Wang D, et al. The significance of glycolysis index and its correlations with immune infiltrates in Alzheimer\u2019s disease. Front Immunol. 2022. https:\/\/doi.org\/10.3389\/fimmu.2022.960906.","journal-title":"Front Immunol"},{"key":"1063_CR16","doi-asserted-by":"publisher","first-page":"1474","DOI":"10.1002\/alz.12310","volume":"17","author":"ER Saito","year":"2021","unstructured":"Saito ER, Miller JB, Harari O, Cruchaga C, Mihindukulasuriya KA, Kauwe JSK, et al. Alzheimer\u2019s disease alters oligodendrocytic glycolytic and ketolytic gene expression. Alzheimer Dementia. 2021;17:1474\u201386.","journal-title":"Alzheimer Dementia"},{"key":"1063_CR17","doi-asserted-by":"publisher","first-page":"5702","DOI":"10.1038\/s41380-021-01068-3","volume":"26","author":"W-I Ryu","year":"2021","unstructured":"Ryu W-I, Bormann MK, Shen M, Kim D, Forester B, Park Y, et al. Brain cells derived from Alzheimer\u2019s disease patients have multiple specific innate abnormalities in energy metabolism. Mol Psychiatry. 2021;26:5702\u201314.","journal-title":"Mol Psychiatry"},{"key":"1063_CR18","first-page":"A261","volume":"16","author":"TL Gilbert","year":"2018","unstructured":"Gilbert TL. The Allen brain atlas as a resource for teaching undergraduate neuroscience. J Undergrad Neurosci Educ. 2018;16:A261\u20137.","journal-title":"J Undergrad Neurosci Educ"},{"key":"1063_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41392-022-01211-8","volume":"7","author":"K Wang","year":"2022","unstructured":"Wang K, Liu H, Hu Q, Wang L, Liu J, Zheng Z, et al. Epigenetic regulation of aging: implications for interventions of aging and diseases. Sig Transduct Target Ther. 2022;7:1\u201322.","journal-title":"Sig Transduct Target Ther"},{"key":"1063_CR20","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2022.884667","volume":"16","author":"C Zhou","year":"2022","unstructured":"Zhou C, Ni W, Zhu T, Dong S, Sun P, Hua F. Cellular reprogramming and its potential application in Alzheimer\u2019s disease. Front Neurosci. 2022;16: 884667.","journal-title":"Front Neurosci"},{"key":"1063_CR21","doi-asserted-by":"publisher","first-page":"705","DOI":"10.1016\/j.stem.2015.09.001","volume":"17","author":"J Mertens","year":"2015","unstructured":"Mertens J, Paquola ACM, Ku M, Hatch E, B\u00f6hnke L, Ladjevardi S, et al. Directly reprogrammed human neurons retain aging-associated transcriptomic signatures and reveal age-related nucleocytoplasmic defects. Cell Stem Cell. 2015;17:705\u201318.","journal-title":"Cell Stem Cell"},{"key":"1063_CR22","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1038\/nbt.3070","volume":"33","author":"TM Schlaeger","year":"2015","unstructured":"Schlaeger TM, Daheron L, Brickler TR, Entwisle S, Chan K, Cianci A, et al. A comparison of non-integrating reprogramming methods. Nat Biotechnol. 2015;33:58\u201363.","journal-title":"Nat Biotechnol"},{"key":"1063_CR23","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1038\/nbt.1529","volume":"27","author":"SM Chambers","year":"2009","unstructured":"Chambers SM, Fasano CA, Papapetrou EP, Tomishima M, Sadelain M, Studer L. Highly efficient neural conversion of human ES and iPS cells by dual inhibition of SMAD signaling. Nat Biotechnol. 2009;27:275\u201380.","journal-title":"Nat Biotechnol"},{"key":"1063_CR24","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.3390\/ijms22031203","volume":"22","author":"L Qian","year":"2021","unstructured":"Qian L, Tcw J. Human iPSC-based modeling of central nerve system disorders for drug discovery. Int J Mol Sci. 2021;22:1203.","journal-title":"Int J Mol Sci"},{"key":"1063_CR25","doi-asserted-by":"publisher","first-page":"228","DOI":"10.1186\/s12864-019-5608-2","volume":"20","author":"S Loontiens","year":"2019","unstructured":"Loontiens S, Depestel L, Vanhauwaert S, Dewyn G, Gistelinck C, Verboom K, et al. Purification of high-quality RNA from a small number of fluorescence activated cell sorted zebrafish cells for RNA sequencing purposes. BMC Genomics. 2019;20:228.","journal-title":"BMC Genomics"},{"key":"1063_CR26","unstructured":"Taking appropriate QC measures for RRBS-type or other -Seq applications with TrimGalore! Babraham Bioinformatics. 2019; https:\/\/github.com\/FelixKrueger\/TrimGalore\/blob\/master\/Docs\/Trim_Galore_User_Guide.md."},{"key":"1063_CR27","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nbt.3519","volume":"34","author":"NL Bray","year":"2016","unstructured":"Bray NL, Pimentel H, Melsted P, Pachter L. Near-optimal probabilistic RNA-seq quantification. Nat Biotechnol. 2016;34:525\u20137.","journal-title":"Nat Biotechnol"},{"key":"1063_CR28","doi-asserted-by":"publisher","first-page":"1521","DOI":"10.12688\/f1000research.7563.2","volume":"4","author":"C Soneson","year":"2016","unstructured":"Soneson C, Love MI, Robinson MD. Differential analyses for RNA-seq: transcript-level estimates improve gene-level inferences. F1000Res. 2016;4:1521.","journal-title":"F1000Res"},{"key":"1063_CR29","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2009","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2009;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"1063_CR30","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/gkv007","volume":"43","author":"ME Ritchie","year":"2015","unstructured":"Ritchie ME, Phipson B, Wu D, Hu Y, Law CW, Shi W, et al. limma powers differential expression analyses for RNA-sequencing and microarray studies. Nucleic Acids Res. 2015;43: e47.","journal-title":"Nucleic Acids Res"},{"key":"1063_CR31","doi-asserted-by":"publisher","first-page":"2050","DOI":"10.1093\/bioinformatics\/btx094","volume":"33","author":"S Su","year":"2017","unstructured":"Su S, Law CW, Ah-Cann C, Asselin-Labat M-L, Blewitt ME, Ritchie ME. Glimma: interactive graphics for gene expression analysis. Bioinformatics. 2017;33:2050\u20132.","journal-title":"Bioinformatics"},{"key":"1063_CR32","unstructured":"McInnes L, Healy J, Melville J. UMAP: uniform manifold approximation and projection for dimension reduction. arXiv; 2020. Available from: http:\/\/arxiv.org\/abs\/1802.03426. Accessed 18 Mar 2023."},{"key":"1063_CR33","doi-asserted-by":"publisher","first-page":"btad279","DOI":"10.1093\/bioinformatics\/btad279","volume":"39","author":"KA Dill-McFarland","year":"2023","unstructured":"Dill-McFarland KA, Mitchell K, Batchu S, Segnitz RM, Benson B, Janczyk T, et al. Kimma: flexible linear mixed effects modeling with kinship covariance for RNA-seq data. Bioinformatics. 2023;39:btad279.","journal-title":"Bioinformatics"},{"key":"1063_CR34","doi-asserted-by":"publisher","first-page":"2322","DOI":"10.1093\/bioinformatics\/bty109","volume":"34","author":"JG P\u00e9rez-Silva","year":"2018","unstructured":"P\u00e9rez-Silva JG, Araujo-Voces M, Quesada V. nVenn: generalized, quasi-proportional Venn and Euler diagrams. Bioinformatics. 2018;34:2322\u20134.","journal-title":"Bioinformatics"},{"key":"1063_CR35","unstructured":"base-package: The R Base Package. https:\/\/rdrr.io\/r\/base\/base-package.html. Accessed 18 Mar 2023."},{"key":"1063_CR36","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1007\/s00357-014-9161-z","volume":"31","author":"F Murtagh","year":"2014","unstructured":"Murtagh F, Legendre P. Ward\u2019s hierarchical agglomerative clustering method: which algorithms implement ward\u2019s criterion? J Classif. 2014;31:274\u201395.","journal-title":"J Classif"},{"key":"1063_CR37","unstructured":"stats-package: The R Stats Package. https:\/\/rdrr.io\/r\/stats\/stats-package.html. Accessed 18 Mar 2023."},{"key":"1063_CR38","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1038\/s41593-020-00764-7","volume":"24","author":"K Leng","year":"2021","unstructured":"Leng K, Li E, Eser R, Piergies A, Sit R, Tan M, et al. Molecular characterization of selectively vulnerable neurons in Alzheimer\u2019s disease. Nat Neurosci. 2021;24:276\u201387.","journal-title":"Nat Neurosci"}],"container-title":["Molecular Brain"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-023-01063-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s13041-023-01063-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13041-023-01063-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,3]],"date-time":"2023-11-03T10:06:50Z","timestamp":1699006010000},"score":1,"resource":{"primary":{"URL":"https:\/\/molecularbrain.biomedcentral.com\/articles\/10.1186\/s13041-023-01063-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,3]]},"references-count":38,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["1063"],"URL":"https:\/\/doi.org\/10.1186\/s13041-023-01063-5","relation":{},"ISSN":["1756-6606"],"issn-type":[{"value":"1756-6606","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,3]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"3 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Patient and subject fibroblasts for iPSC-derived neuron generation were obtained from the UC San Diego Shiley-Marcos Alzheimer\u2019s Disease Research Center (UCSD ADRC) in accordance with UC San Diego IRB approval.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"All subjects have consented to neuron analysis in accordance with UCSD IRB Protocol 180797 (Douglas Galasko, PI) and IRB approval.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}